MAPT and Alzheimer disease: A neurodegenerative disorder with various pathobiologic subtypes and clinical presentations [3], AD is defined by neuropathologic changes, including amyloid-beta (Aβ) plaques comprised of aggregated Aβ and neurofibrillary tangles containing aggregated tau proteins [4].